Dr. Gregory A. Otterson MD Medical Oncologist

Dr. Gregory Otterson is a medical oncologist in Columbus, Ohio and is affiliated with multiple hospitals in the area, including James Cancer Hospital and Solove Research Institute and Ohio State University Hospital. He received his medical degree from Georgetown University School of Medicine and has been in practice for 28 years. He is one of 21 doctors at James Cancer Hospital and Solove Research Institute and one of 17 at Ohio State University Hospital who specialize in Medical Oncology.

Are you Dr. Otterson? Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Hospital Affiliation

Ohio State University Wexner Medical Center
Ranked #30 in Cancer

Ohio State University Hospital

James Cancer Hospital and Solove Research Institute
Ranked #30 in Cancer

Education & Medical Training

Rush University Medical Center
Residency, Internal Medicine, 1986–1989

National Institutes of Health Clinical Center
Fellowship, Medical Oncology, 1989–1992

Georgetown University School of Medicine
Class of 1986

Certifications & Licensure

American Board of Family Medicine
Certified in Family Medicine

American Board of Ophthalmology
Certified in Ophthalmology

CA State Medical License
Active through 2014

Awards, Honors & Recognition

Patient-Centered Medical Home Recognition Program, National Committee for Quality Assurance
2012

Patient-Centered Medical Home Recognition Program, National Committee for Quality Assurance
2013

Patient-Centered Medical Home Recognition Program, National Committee for Quality Assurance
2014

Patient-Centered Medical Home Recognition Program, National Committee for Quality Assurance
2015

Physician Practice Connections Recognition Program, National Committee for Quality Assurance
2012

Physician Practice Connections Recognition Program, National Committee for Quality Assurance
2013

Physician Practice Connections Recognition Program, National Committee for Quality Assurance
2014

Physician Practice Connections Recognition Program, National Committee for Quality Assurance
2015

Meaningful Use Stage 1 Certification, Centers for Medicare & Medicaid Services
2011

Publications & Presentations

CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancer.
Heist, R. S.,Wang, X.,Hodgson, L.,Otterson, G. A.,Stinchcombe, T. E.,Gandhi, L.,Villalona-Calero, M. A.,Watson, P.,Vokes, E. E.,Socinski, M. A.

NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation.
Eisfeld, A. K.,Schwind, S.,Hoag, K. W.,Walker, C. J.,Liyanarachchi, S.,Patel, R.,Huang, X.,Markowitz, J.,Duan, W.,Otterson, G. A.,Carson, W. E.,Marcucci, G.,Bloomfield, C. D.,de la Chapelle, A.

Detection of Extracellular RNAs in Cancer and Viral Infection via Tethered Cationic Lipoplex Nanoparticles Containing Molecular Beacons.
Wu, Y.,Kwak, K. J.,Agarwal, K.,Marras, A.,Wang, C.,Mao, Y.,Huang, X.,Ma, J.,Yu, B.,Lee, R.,Vachani, A.,Marcucci, G.,Byrd, J. C.,Muthusamy, N.,Otterson, G.,Huang, K.,Castro, C. E.,Paulaitis, M.,Nana-Sinkam, S. P.,Lee, L. J.

See all 43 publications

Report a Correction — If you are aware of information on this page that is out of date or incorrect, please let us know.

Patient Advice & Support


See More
Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.